4th - 5th November 2021 (GMT+00:00) GMT
Up to 18 CPD credits available
View Congress programme
Day one (Thursday 4 November)
Key note speakers
Anyone with an interest and passion for radiology, radiation oncology and the underlying sciences, including radiologists, physicists, radiographers, oncologists, physicians, radiation protection advisers and supervisors.
To secure sponsorship at the congress, please contact us at firstname.lastname@example.org
We are very grateful to the following organisations for supporting this event.
Advanced Accelerator Applications, S.A. (AAA), a Novartis company, is an innovative medicines company developing targeted radioligand therapies and precision imaging radioligands for oncology. We are committed to transforming patients’ lives by leading innovation in nuclear medicine. AAA currently has over 1,000 employees working across 31 sites in 12 countries (Canada, France, Germany, Israel, Italy, the Netherlands, Poland, Portugal, Spain, Switzerland, the UK and the US). The company also has global manufacturing capabilities with 19 facilities in eight countries, and six research & development sites. For more information, please visit: https://www.adacap.com/.
Aidence rallies the brightest minds in deep learning and radiology to create Veye Chest, an AI-based assistant for lung nodules on chest CT. Cutting through the hype around AI, we bring applications that add value for radiologists. Veye Chest is currently running in Lung Health Checks pilot sites and in routine practice across the UK.
Bayer’s Radiology business is well placed to be the partner of choice in helping NHS trusts to address the many challenges faced today including the increasing need for governance to demonstrate best practice and improving patient care within increasing financial constraints. With market-leading contrast media and power injector systems, Bayer is able to offer innovative patient care and with the addition of its informatics platform, it can support radiology departments in driving protocol standardisation and easily accessible audit data that enable departments to meet further challenges faced around contrast and radiation dose management. 0118 2063999 www.radiology.bayer.co.uk
contextflow empowers radiologists to complete their daily workload faster and with higher quality and cost-efficiency by delivering a unique and scalable AI backbone that fully integrates into clinical workflows. Its core technology includes SEARCH, a 3D image-based search engine, which provides relevant statistics, reference cases and differential diagnosis information at the point of care within seconds. It currently supports 18+ disease patterns in lung CTs, including those related to COVID-19. TRIAGE is a separate tool that allows radiologists to reorder their worklist based on the presence of specific or time-critical findings. All contextflow products are developed in close collaboration with practicing radiologists and thus integrate directly into your RIS/PACS. contextflow is a spin-off of the Medical University of Vienna (MUW), Technical University of Vienna (TU) and European research project KHRESMOI. It was founded by a team of AI and engineering experts in July 2016. It is currently testing its software with 10+ partner hospitals and clinics throughout Europe. contextflow: See beyond a single case.
GE Healthcare is a leading provider of medical imaging, monitoring, and life science technologies. GE Healthcare enables precision health in diagnostics, therapeutics and monitoring through intelligent devices, data analytics, applications and services to help providers, researchers and life sciences companies in their mission to improve outcomes for patients around the world.
NeoDynamics AB (publ) is a Swedish Med Tech Company dedicated to advancing diagnosis and care of breast cancer. The company has developed an innovative precision biopsy system called NeoNavia. The NeoNavia system was developed based on research at the Karolinska Institutet in Sweden where patented “Pulse” technology was found to be beneficial in improving outcomes for biopsy procedures, namely, offering clinicians and patients accurate lesion targeting and high tissue yield, aiding correct diagnosis and individualized treatment. NeoNavia is currently being evaluated at leading clinics in UK as part of the COMPULSE study. We at Neodynamics want to contribute to better diagnostic methods for the millions of women in the world who suffer from breast cancer each year, thereby increasing the chances of survival. Anna Eriksrud, CEO.
Enabling better health and better care at lower cost Philips is a leading health technology company focused on improving people`s lives across the health continuum - from healthy living and prevention, to diagnosis, treatment and home care. Applying advanced technologies and deep clinical and consumer insights, Philips delivers integrated solutions that improve people`s health and enable better outcomes. Partnering with its customers, Philips seeks to transform how healthcare is delivered and experienced. The company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. www.philips.co.uk/healthcare
At Siemens Healthineers, our purpose is to enable healthcare providers to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, and improving patient experience, all enabled by digitalising healthcare. An estimated 5 million patients globally everyday benefit from our innovative technologies and services in the areas of diagnostic and therapeutic imaging, laboratory diagnostics and molecular medicine, as well as digital health and enterprise services. We are a leading medical technology company with over 170 years of experience and 18,000 patents globally. With more than 48,000 dedicated colleagues in 75 countries, we will continue to innovate and shape the future of healthcare. For more information and latest product line, please visit www.healthcare.siemens.co.uk